Swiss pharma giant Novartis said it would make growth in the United States its top geographic priority, even after laws were passed to rein in drug prices in the world’s largest pharmaceutical market.
Cancer detection test maker Grail, acquired by Illumina Inc. last year despite ongoing antitrust challenges, on Tuesday said it would expand use of its flagship Galleri cancer diagnostic test through a new agreement with life insurer John Hancock, a division of Manulife Financial.
Haleon believes it is not liable for any claims that may arise from U.S. litigation over the heartburn drug Zantac, the London-listed company’s CEO Brian McNamara told Reuters on Tuesday.
Teva Pharmaceutical Industries expects to finalize an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday, while confirming he was unlikely to renew his contract next year.
U.S. President Joe Biden said in an interview aired on Sunday that “the pandemic is over,” even though the country continues to grapple with coronavirus infections that kill hundreds of Americans daily.
U.S. Centers of Disease Control and Prevention (CDC) Director Rochelle Walensky said on Thursday she was cautiously optimistic over a decline in the growth of new monkeypox cases, but that some areas of the country are still experiencing a rise in infections.
Two days after unveiling an executive order to boost U.S. biomanufacturing, the White House revealed plans that include $2 billion to support the initiative.
New COVID-19 boosters aimed at fighting currently circulating variants of the coronavirus will be widely available this week, U.S. health officials said on Tuesday, adding that the vaccine is moving closer to an annual jab, as with flu shots.
New infections with monkeypox are steadily declining in Spain, which has recorded the world’s second-highest tally of cases in this year’s global outbreak, Health Minister Carolina Darias said on Monday.
The FDA has approved Boehringer Ingelheim’s Spevigo (spesolimab) for generalized pustular psoriasis (GPP) flares in adults, making it the first drug approved for this indication.